1. background introduction

Chronic disease is a general term for diseases that do not constitute infection and long-term accumulation to form disease damage. It mainly includes diseases such as hypertension, diabetes, tumors, and chronic obstructive pulmonary disease. According to data from the Champ Consulting Group, there are410010 million deaths from chronic non-communicable diseases, accounting71%. Of these, cardiovascular disease (such as heart disease and stroke) is the most common cause of death, causing1780Ten thousand deaths, accounting for the total number of deaths worldwide31%; followed by cancer (900Thousands of deaths, accounting15%), respiratory diseases (400Thousands of deaths, accounting7%) and diabetes (140Thousands of deaths, accounting3%）。

As the most populous country in the world, China is also facing severe challenges in the prevention and control of chronic non-communicable diseases. With the continuous improvement of my country's economic and social development and the continuous improvement of health services, the average life expectancy of residents continues to increase, and the survival period of patients with chronic diseases continues to extend. The base of patients with chronic diseases in my country will continue to expand. According to data from the Champ Consulting Group, the average life expectancy of our residents has changed from2020of the year77.93Age raised2021of the year78.2Years old.2022Our average life expectancy reached78.5Years old. From the perspective of population structure, our country65The proportion of the elderly population aged and above in the total population reached14.2%It marks the official entry of our country.“aging society”, is expected2030years will exceed20%. In our country's elderly population, there are nearly1.5Hundreds of millions of people are suffering from chronic diseases, and the aging of the population structure will have a certain impact on the medical service system related to chronic diseases.

In addition, the superposition of influencing factors such as environmental pollution, irregular lifestyles, and excessive pressure loads has also led to an increasing number of chronic disease patients in China. Take diabetes, for example,2012-2022Over the decade of the year, the number of people with diabetes in China has increased from9000million has grown.1.4It has reached one-tenth of the country's population.

Chronic non-communicable diseases not only impose a huge health and economic burden on individuals and families, but also cause significant socio-economic losses to society and countries. According to data from the Champ Consulting Group,2022The direct medical costs of chronic non-communicable diseases in China were2.7Trillion yuan, accounting for that yearGDPof2.6%; and indirect losses (including death, disability, absence from work, etc.) up5.6Trillion yuan, accounting for that yearGDPof5.4%. expected2023At the end of the year, these two losses will grow3.1trillions of dollars and6.4Trillion yuan, accounting for that yearGDPof4.1%and8.5%。

Therefore, strengthening the prevention and control of chronic non-communicable diseases, improving the quality of life and health of patients, and reducing the social and economic burden are major public health and social problems facing my country at present and in the future. Chronic disease management, as a comprehensive health management model that focuses on prevention, health promotion, self-management, continuous management, and aims to reduce morbidity and mortality, is one of the effective ways to solve this problem.

2. policy driven

In 2012, the management and prevention of chronic diseases was included in the government work plan for the first time in China.2015Since then, China has issued a series of policies for the development planning, service standards and system construction of the chronic disease management industry, aiming to promote the development of the chronic disease management industry.

"Healthy China2030”The outline of the plan proposes to establish a basic public health service system covering urban and rural residents, strengthen health management services for key groups, establish and improve the two-way referral system between primary medical and health institutions and higher-level hospitals, promote the construction of hierarchical diagnosis and treatment system, improve the reform of medical insurance payment methods, and strengthen the Internet+Medical and health applications, promote the innovation and development of the health industry, etc.

On Deepening Medical Health Opinions on the Reform of the Health System ", proposed to improve the multi-level medical security system of basic medical insurance, critical illness insurance, medical assistance and supplementary medical insurance, establish and improve the reimbursement policy for chronic disease outpatient expenses, explore the establishment of chronic disease management service packages, and promote the inclusion of chronic disease management services. The scope of medical insurance payment; promote the reform of medical insurance payment methods, and explore the implementation of payment per head, disease, and diagnosis and treatment process; we will strengthen the construction of grass-roots medical and health institutions and improve the capacity and level of grass-roots medical and health services.

About doing well2021Notice on the Work of Basic Public Health Service Projects in ", proposed to provide targeted services for patients with chronic diseases, including the establishment of health records, health education, health consultation, health assessment, health guidance, etc.; to strengthen the prevention and treatment of chronic non-communicable diseases, including hypertension,2Standardized management of people with type 1 diabetes and severe mental disorders; To promote the Internet+Basic public health services, using the Internet platform to provide remote consultation, follow-up, appointment and other services.

It can be seen that in recent years, the Chinese government has attached great importance to and strongly supported the chronic disease management industry, and issued a series of policies and measures conducive to the development of the industry. In particular, under the influence of the new coronary pneumonia epidemic, the Chinese government has paid more attention to strengthening the construction of the public health system and the health protection of the people, promoting the Internet+The development and application of health care has brought new opportunities and challenges to the chronic disease management industry.

3. technology driven

With the continuous expansion of the base of chronic disease patients, the traditional extensive chronic disease management model is difficult to meet the actual needs of our country, driven by new technologies. Various software and hardware tools with big data, artificial intelligence, Internet of Things and other technologies as the core began to penetrate into all aspects of chronic disease management. Mainly include the following aspects:

On the basis of collecting and monitoring the health data of patients with chronic diseases, big data technology can establish health evaluation and early warning, formulate personalized treatment plan and follow-up for patients with chronic diseases, which can not only improve the efficiency of chronic disease management, but also help patients reduce medical expenses and effectively improve the prognosis of diseases. For example, health management enterprises can rely on big data technology to provide users with health monitoring for a long time, and formulate personalized life intervention programs for them on the basis of a large amount of health data to help them form a good lifestyle and reduce the incidence rate; in the medication stage, chronic disease management enterprises can cooperate with pharmaceutical and pharmaceutical equipment enterprises by analyzing their accumulated user data to provide patients with appropriate drugs and equipment.

Artificial intelligence technology can realize intelligent consultation, intelligent auxiliary diagnosis, intelligent medication guidance and other services for patients with chronic diseases through natural language processing, image recognition, voice recognition and other means, which improves the accuracy and timeliness of diagnosis and reduces the workload of doctors and the risk of misdiagnosis. For example, the Internet medical platform can use artificial intelligence technology to provide users with online inquiry services, collect users' basic information, symptom descriptions, past history, etc. through an intelligent question-and-answer system, combine medical knowledge base and big data analysis, give preliminary diagnosis results and suggestions, and transfer users to professional doctors for follow-up. In the medication phase, artificial intelligence technology can be based on the user's medication records, physical characteristics, allergic reactions and other information, recommend appropriate drugs for users, and remind users to pay attention to drug contraindications and side effects.

Internet of things technology can realize real-time monitoring, remote management, intelligent reminding and other services for patients with chronic diseases through various wearable devices and mobile terminals, which improves the convenience and effectiveness of management and enhances patients' self-management awareness and ability. For example, wearable devices can collect physiological indexes such as blood pressure, blood sugar and heart rate of users in real time, and transmit them to the cloud platform for analysis and storage through wireless network. At the same time, they can feed back the monitoring results to users and doctors and give early warning according to the set threshold. In the medication phase, Internet of Things technology can provide users with medication reminders, medication statistics, medication consultation and other services through devices such as intelligent medicine boxes.

The above technological innovations have brought new opportunities and challenges to the chronic disease management industry, and also provided strong technical support and guarantee for the development of the industry.

4. market size

According to data from the Champ Consulting Group,2022China's chronic disease management market size is.7.2Trillion yuan, year-on-year growth15%, affected by supply and demand, is expected2023The whole year is expected to exceed 8 trillion yuan, up year on year.11.31%. Among them, according to the type of chronic disease, hypertension, diabetes, cancer, etc. are the main segments of the chronic disease management market, accounting for the majority of the market share. By service type, the chronic disease management market mainly includes health assessment, risk intervention, diagnosis and treatment, medication guidance, follow-up monitoring and other services, of which diagnosis and treatment and medication guidance are the core links of the market, but also the main source of revenue for the market. According to the service mode, the chronic disease management market mainly includes offline services and online services, in which offline services are mainly traditional medical institutions and pharmacies, and online services are mainly Internet medical platforms and health management platforms. With the development and application of Internet technology, the market share of online services is increasing year by year.2023The end of the year will occupy the market40%Above.

5. industry chain structure

According to the chronic disease management process, the upstream of its industrial chain is mainly composed of health management institutions and medical examination institutions. Among them, the physical examination institutions carry out risk assessment and health intervention on the basis of the user's health information obtained in the process of physical examination, which is more authoritative and guiding by the results of physical examination. However, most of the current physical examination institutions in my country are still insufficient in terms of personalized physical examination suggestions and management services after physical examination; health management institutions are mostly developed from physical examination institutions, and in addition to physical examination services, they also provide health consultations, health lectures, etc. Health promotion projects mobilize the enthusiasm of patients, so that they can self-monitor, self-manage, and consciously carry out health plans.

The middle reaches of the industrial chain consist of professional medical institutions and online consultation platforms. Medical institutions are mainly involved in the management of chronic diseases in the form of inquiry and diagnosis, which is the most important treatment channel for patients with chronic diseases. Most patients with chronic diseases have high barriers to obtaining prescription drugs for a long time and need to be prescribed by professional medical institutions after diagnosis. At present, although China is actively promoting graded diagnosis and treatment, but the penetration rate is far from enough, the development of online consultation platform effectively complements the patient's part of the overflow demand.

The downstream of the industrial chain consists of pharmaceutical enterprises, medical equipment enterprises, pharmacies and other offline chronic disease management enterprises and Internet chronic disease management enterprises. Among them, pharmaceutical enterprises and pharmaceutical enterprises mainly provide patients with chronic disease management drugs and equipment and other products, offline pharmacies can provide both chronic disease management products, but also provide offline chronic disease management services. At present, China's four major chain pharmacies (Dachenlin, the people, Yifeng pharmacy, Yixiantang) have laid out the field of chronic disease management, gradually formed a unique chronic disease management model, chronic disease management has become an important growth point of offline pharmacies, is expected to continue to deepen the layout in the future. Internet chronic disease management enterprises rely on the Internet platform docking pharmaceutical enterprises, pharmacies, etc., to provide online services for patients.

6. development trend

Under the policy tilt and the deepening integration of related technologies, more and more enterprises will cut into the chronic disease management track, and constantly broaden the development space of the industry. Champu Consulting believes that the future of China's chronic disease management industry will show the following trends:

First, chronic disease management services will be more refined and personalized. With the application of big data, artificial intelligence and other technologies, chronic disease management companies will be able to more accurately identify and classify the risk levels and demand types of chronic disease patients, and provide different patients with service plans that are more in line with their characteristics and needs. Improve the pertinence and satisfaction of services.

Second, chronic disease management services will be more diversified and integrated. With the intensification of competition in the chronic disease management industry, a single service model will be difficult to meet the diverse needs of patients. Chronic disease management companies will provide patients with health assessment, risk intervention, diagnosis and treatment through cross-border cooperation and platform integration., Medication guidance, follow-up monitoring and other full-process one-stop services to improve service coverage and continuity.

Third, chronic disease management services will be more intelligent and convenient. With the Internet of Things,5GWith the development and popularization of technology, chronic disease management enterprises will be able to realize real-time monitoring, remote management, intelligent reminding and other services for patients through various wearable devices and mobile terminals, so as to improve the convenience and effectiveness of services and enhance patients' self-management awareness and ability.

To sum up,2023The analysis of the development status of China's chronic disease management industry is as follows:

Chronic disease is a general term for diseases that do not constitute infection and long-term accumulation to form disease damage. It mainly includes diseases such as hypertension, diabetes, tumors, and chronic obstructive pulmonary disease. With the continuous improvement of my country's economic and social development and the continuous improvement of health services, the average life expectancy of residents continues to increase, and the survival period of patients with chronic diseases continues to extend. The base of patients with chronic diseases in my country will continue to expand, and the situation of chronic disease prevention and control is becoming more and more severe.

In recent years, the Chinese government has attached great importance to and strongly supported the chronic disease management industry, and issued a series of policies and measures conducive to the development of the industry. In particular, under the influence of the new coronary pneumonia epidemic, the Chinese government has paid more attention to strengthening the construction of the public health system and the health protection of the people, promoting the Internet+The development and application of health care has brought new opportunities and challenges to the chronic disease management industry.

With the development and application of big data, artificial intelligence, Internet of Things and other technologies, new technological innovation and service models have emerged in the chronic disease management industry, providing strong technical support and guarantee for the development of the industry. These technological innovations provide patients with more refined, personalized, diversified, integrated, intelligent and convenient services, and improve the quality and efficiency of the development of the industry.

According to data from the Champ Consulting Group,2022China's chronic disease management market size is.7.2Trillion yuan, year-on-year growth15%, affected by supply and demand, is expected2023The whole year is expected to exceed 8 trillion yuan, up year on year.11.31%. Among them, according to the type of chronic disease, hypertension, diabetes, cancer, etc. are the main segments of the chronic disease management market, accounting for the majority of the market share. By service type, the chronic disease management market mainly includes health assessment, risk intervention, diagnosis and treatment, medication guidance, follow-up monitoring and other services, of which diagnosis and treatment and medication guidance are the core links of the market, but also the main source of revenue for the market. According to the service mode, the chronic disease management market mainly includes offline services and online services, in which offline services are mainly traditional medical institutions and pharmacies, and online services are mainly Internet medical platforms and health management platforms. With the development and popularization of Internet technology, the market share of online services is increasing year by year.2023The end of the year will occupy the market40%Above.

According to the chronic disease management process, the upstream of the industrial chain is mainly composed of health management institutions and physical examination institutions, the middle reaches of the industrial chain are composed of professional medical institutions and online consultation platforms, and the downstream of the industrial chain is composed of pharmaceutical enterprises, medical equipment enterprises, pharmacies and other offline chronic disease management enterprises and Internet chronic disease management enterprises. In all aspects of the industrial chain, all kinds of enterprises are actively exploring new cooperation models and business models to improve their competitiveness and profitability.

Under the policy tilt and the deepening integration of related technologies, more and more enterprises will cut into the chronic disease management track, and constantly broaden the development space of the industry. In the future, China's chronic disease management industry will show a development trend of more refined and personalized, more diversified and integrated, more intelligent and convenient.